Typical Antipsychotic [EPC]

Typical Antipsychotic [EPC] was reported 25054 times

Drugs of the Typical Antipsychotic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MYOCARDIAL REPERFUSION INJURY 18 0.4737
1 PAROXYSMAL PERCEPTUAL ALTERATION 27 0.4500
2 ENCEPHALITIS TOXIC 19 0.2405
3 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 158 0.2287
4 MALIGNANT CATATONIA 60 0.2281
5 DELUSION OF GRANDEUR 79 0.1759
6 REFUSAL OF EXAMINATION 21 0.1603
7 NEUROLEPTIC MALIGNANT SYNDROME 1668 0.1405
8 SPASMODIC DYSPHONIA 41 0.1353
9 WAXY FLEXIBILITY 22 0.1250
10 COGWHEEL RIGIDITY 107 0.1019
11 DISINHIBITION 153 0.0950
12 CATATONIA 451 0.0858
13 ECHOLALIA 25 0.0786
14 OSCILLOPSIA 18 0.0695
15 COLONIC PSEUDO-OBSTRUCTION 19 0.0681
16 OROMANDIBULAR DYSTONIA 49 0.0672
17 ANTICHOLINERGIC SYNDROME 106 0.0665
18 NEGLECT OF PERSONAL APPEARANCE 16 0.0658
19 RESTING TREMOR 36 0.0557
20 PSYCHOTIC SYMPTOM 115 0.0557
21 SCHIZOPHRENIA, PARANOID TYPE 20 0.0556
22 VISCERAL CONGESTION 28 0.0548
23 GRANDIOSITY 20 0.0546
24 OCULOGYRIC CRISIS 113 0.0526
25 PROTRUSION TONGUE 30 0.0515
26 WATER INTOXICATION 26 0.0514
27 ATRIOVENTRICULAR SEPTAL DEFECT 24 0.0511
28 EXTRAPYRAMIDAL DISORDER 1263 0.0508
29 SCHIZOAFFECTIVE DISORDER 89 0.0499
30 DRUG-GENETIC INTERACTION 17 0.0476
31 EMOTIONAL POVERTY 83 0.0473
32 AKATHISIA 646 0.0473
33 SEXUALLY INAPPROPRIATE BEHAVIOUR 22 0.0472
34 PARKINSONIAN GAIT 29 0.0465
35 PARKINSONISM 451 0.0462
36 LYMPHOCYTE COUNT ABNORMAL 52 0.0462
37 MUTISM 67 0.0461
38 NEGATIVISM 33 0.0435
39 SCHIZOPHRENIA 526 0.0432
40 BLUNTED AFFECT 31 0.0420
41 MASKED FACIES 17 0.0419
42 BLOOD PROLACTIN ABNORMAL 36 0.0417
43 VERBAL ABUSE 20 0.0408
44 POSTURING 21 0.0404
45 HYPERPROLACTINAEMIA 257 0.0396
46 PERSECUTORY DELUSION 98 0.0393
47 NEPHROGENIC DIABETES INSIPIDUS 42 0.0364
48 TORTICOLLIS 77 0.0363
49 MUSCLE RIGIDITY 420 0.0351
50 ENCEPHALITIS AUTOIMMUNE 46 0.0350
51 PRIAPISM 118 0.0342
52 SALIVARY HYPERSECRETION 340 0.0340
53 DYSTONIA 650 0.0335
54 ANTIPSYCHOTIC DRUG LEVEL INCREASED 93 0.0330
55 BORDERLINE PERSONALITY DISORDER 23 0.0324
56 METABOLIC SYNDROME 53 0.0322
57 THERAPEUTIC PRODUCT EFFECT VARIABLE 124 0.0319
58 SEDATION COMPLICATION 80 0.0313
59 EMBOLISM VENOUS 89 0.0293
60 MULTIPLE DRUG THERAPY 22 0.0292
61 PSYCHOMOTOR RETARDATION 80 0.0284
62 HYPERREFLEXIA 99 0.0284
63 DELUSIONAL DISORDER, UNSPECIFIED TYPE 21 0.0281
64 AUTONOMIC NERVOUS SYSTEM IMBALANCE 82 0.0280
65 OPISTHOTONUS 22 0.0277
66 APALLIC SYNDROME 20 0.0275
67 HALLUCINATION, AUDITORY 434 0.0273
68 STUPOR 87 0.0271
69 CHOLINERGIC SYNDROME 17 0.0266
70 HYPERAMMONAEMIC ENCEPHALOPATHY 46 0.0264
71 HYPOPARATHYROIDISM 20 0.0261
72 DELUSION 399 0.0257
73 ADENOMA BENIGN 22 0.0256
74 OBSESSIVE-COMPULSIVE DISORDER 205 0.0255
75 RESPIRATORY ALKALOSIS 41 0.0252
76 SEDATION 655 0.0250
77 TORSADE DE POINTES 195 0.0248
78 SYMPTOM MASKED 18 0.0247
79 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 22 0.0247
80 PRESSURE OF SPEECH 16 0.0246
81 FEELING GUILTY 32 0.0242
82 COMPULSIVE SEXUAL BEHAVIOUR 19 0.0235
83 ANOSOGNOSIA 18 0.0234
84 ILEUS PARALYTIC 104 0.0233
85 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 52 0.0232
86 DIET REFUSAL 17 0.0232
87 GRIMACING 18 0.0230
88 HYPORESPONSIVE TO STIMULI 27 0.0230
89 CHOREA 39 0.0226
90 DEMENTIA WITH LEWY BODIES 25 0.0225
91 DELIRIUM 778 0.0224
92 ELECTROCARDIOGRAM PR PROLONGATION 17 0.0222
93 LIP EROSION 16 0.0219
94 HYPOTHERMIA 221 0.0218
95 PSYCHOTIC DISORDER 643 0.0218
96 APRAXIA 32 0.0216
97 HYPERTHERMIA 164 0.0215
98 DYSLIPIDAEMIA 108 0.0212
99 STEREOTYPY 20 0.0212
100 NUCHAL RIGIDITY 19 0.0210
101 CIRCADIAN RHYTHM SLEEP DISORDER 17 0.0205
102 BRADYKINESIA 117 0.0198
103 REDUCED FACIAL EXPRESSION 20 0.0197
104 MEGACOLON 30 0.0191
105 ELECTROCARDIOGRAM QT PROLONGED 684 0.0190
106 PAROTITIS 22 0.0189
107 GAZE PALSY 32 0.0188
108 RHINALGIA 50 0.0182
109 ACUTE PSYCHOSIS 45 0.0182
110 POLYDIPSIA 71 0.0179
111 CLONUS 49 0.0179
112 TONIC CLONIC MOVEMENTS 23 0.0177
113 BLOOD PROLACTIN INCREASED 83 0.0176
114 MYOCARDITIS 201 0.0175
115 EUPHORIC MOOD 178 0.0174
116 CONSCIOUSNESS FLUCTUATING 18 0.0172
117 DROOLING 117 0.0169
118 NEUTROPHIL COUNT INCREASED 173 0.0169
119 PSYCHIATRIC DECOMPENSATION 33 0.0169
120 EOSINOPHIL COUNT DECREASED 40 0.0168
121 HEAD TITUBATION 23 0.0167
122 HYPERTONIA 95 0.0166
123 GRANULOCYTOPENIA 94 0.0165
124 VULVOVAGINAL CANDIDIASIS 22 0.0163
125 COMA SCALE ABNORMAL 47 0.0162
126 SEROTONIN SYNDROME 308 0.0160
127 MYOCLONUS 184 0.0154
128 SOCIAL AVOIDANT BEHAVIOUR 89 0.0154
129 VICTIM OF CRIME 19 0.0154
130 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 26 0.0154
131 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 40 0.0153
132 LABILE BLOOD PRESSURE 18 0.0152
133 BLOOD CREATINE PHOSPHOKINASE INCREASED 429 0.0149
134 PSYCHOMOTOR HYPERACTIVITY 247 0.0149
135 HYPERTHERMIA MALIGNANT 22 0.0148
136 AKINESIA 30 0.0145
137 SUDDEN CARDIAC DEATH 49 0.0144
138 HALLUCINATIONS, MIXED 60 0.0143
139 INTESTINAL DILATATION 19 0.0142
140 TARDIVE DYSKINESIA 395 0.0140
141 URETERIC OBSTRUCTION 19 0.0139
142 DISTRACTIBILITY 16 0.0139
143 RESUSCITATION 23 0.0139
144 ELECTROENCEPHALOGRAM ABNORMAL 43 0.0136
145 ELECTROCARDIOGRAM T WAVE ABNORMAL 21 0.0134
146 MANIA 213 0.0129
147 BLOOD PHOSPHORUS DECREASED 46 0.0126
148 DRUG CLEARANCE DECREASED 16 0.0122
149 AFFECTIVE DISORDER 96 0.0122
150 HYPERAMMONAEMIA 61 0.0122
151 AGITATION 882 0.0120
152 TROPONIN I INCREASED 20 0.0120
153 SELF INJURIOUS BEHAVIOUR 36 0.0118
154 AGGRESSION 589 0.0118
155 PITUITARY TUMOUR BENIGN 19 0.0116
156 HYPERNATRAEMIA 58 0.0116
157 PNEUMONIA ASPIRATION 290 0.0116
158 POSTURE ABNORMAL 37 0.0114
159 INAPPROPRIATE AFFECT 18 0.0113
160 HYPERKINESIA 24 0.0113
161 RENAL NEOPLASM 24 0.0113
162 DRUG INTERACTION 1779 0.0112
163 VENTRICULAR ARRHYTHMIA 41 0.0112
164 METABOLIC DISORDER 65 0.0112
165 STARING 27 0.0112
166 BLOOD BICARBONATE DECREASED 21 0.0111
167 REFUSAL OF TREATMENT BY PATIENT 72 0.0110
168 HOSTILITY 28 0.0110
169 HYPERSEXUALITY 20 0.0109
170 DRUG LEVEL INCREASED 179 0.0108
171 OBESITY 172 0.0108
172 THERAPEUTIC AGENT TOXICITY 36 0.0108
173 FAECALOMA 59 0.0108
174 TONGUE BITING 22 0.0107
175 VENOUS THROMBOSIS LIMB 22 0.0107
176 IMPULSIVE BEHAVIOUR 40 0.0106
177 TIC 58 0.0106
178 RHABDOMYOLYSIS 443 0.0106
179 PARADOXICAL DRUG REACTION 39 0.0106
180 BEHAVIOUR DISORDER 57 0.0105
181 LEUKOCYTOSIS 190 0.0105
182 PARANOIA 181 0.0105
183 COMMUNICATION DISORDER 40 0.0104
184 HYPOREFLEXIA 20 0.0104
185 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 107 0.0104
186 MENTAL IMPAIRMENT 252 0.0104
187 INCREASED APPETITE 198 0.0104
188 RESTLESSNESS 378 0.0103
189 HYPOTONIA NEONATAL 16 0.0102
190 PARAPARESIS 18 0.0101
191 CEREBRAL ATROPHY 40 0.0100
192 BRAIN DEATH 31 0.0100
193 LONG QT SYNDROME 24 0.0100
194 DEPRESSIVE SYMPTOM 35 0.0099
195 ANTICONVULSANT DRUG LEVEL INCREASED 16 0.0099
196 TRISMUS 51 0.0099
197 SUICIDE ATTEMPT 598 0.0099
198 DYSMORPHISM 23 0.0098
199 DEPRESSED LEVEL OF CONSCIOUSNESS 386 0.0097
200 ALTERED STATE OF CONSCIOUSNESS 211 0.0097
201 HYPERLACTACIDAEMIA 26 0.0097
202 ILLUSION 16 0.0097
203 GALACTORRHOEA 62 0.0096
204 SOPOR 127 0.0096
205 PANCREATITIS NECROTISING 22 0.0096
206 PHYSICAL ASSAULT 20 0.0096
207 SUDDEN DEATH 100 0.0094
208 DIABETIC COMA 26 0.0093
209 DYSKINESIA 365 0.0090
210 HYPERCAPNIA 27 0.0090
211 DRUG MONITORING PROCEDURE NOT PERFORMED 16 0.0089
212 OBSESSIVE THOUGHTS 16 0.0089
213 VOLVULUS 21 0.0089
214 GESTATIONAL DIABETES 42 0.0088
215 SINUS TACHYCARDIA 125 0.0088
216 SINUS BRADYCARDIA 85 0.0088
217 COLITIS ISCHAEMIC 59 0.0087
218 LEUKOPENIA 436 0.0087
219 LEUKAEMIA 82 0.0087
220 INTENTIONAL SELF-INJURY 175 0.0087
221 POTENTIATING DRUG INTERACTION 29 0.0086
222 TACHYPNOEA 116 0.0085
223 SELF-INJURIOUS IDEATION 35 0.0083
224 MENTAL STATUS CHANGES 231 0.0083
225 VENTRICULAR FIBRILLATION 92 0.0083
226 RESPIRATORY DEPRESSION 101 0.0082
227 TREATMENT NONCOMPLIANCE 450 0.0082
228 MIOSIS 66 0.0082
229 BRAIN INJURY 82 0.0082
230 BLOOD SODIUM INCREASED 22 0.0081
231 RESPIRATORY ACIDOSIS 32 0.0081
232 HYPERVENTILATION 47 0.0081
233 EYE MOVEMENT DISORDER 55 0.0080
234 ENCEPHALOPATHY 196 0.0080
235 MUCOSAL DRYNESS 16 0.0079
236 MUSCLE CONTRACTURE 16 0.0079
237 DRUG TOXICITY 107 0.0078
238 IMPAIRED SELF-CARE 16 0.0077
239 TOXIC EPIDERMAL NECROLYSIS 117 0.0077
240 ACCIDENTAL EXPOSURE 32 0.0077
241 MUSCLE CONTRACTIONS INVOLUNTARY 27 0.0077
242 LYMPHOCYTE COUNT INCREASED 25 0.0077
243 UNRESPONSIVE TO STIMULI 196 0.0076
244 KLEBSIELLA INFECTION 38 0.0075
245 BRUXISM 40 0.0074
246 SLOW SPEECH 18 0.0074
247 FEMORAL NECK FRACTURE 38 0.0074
248 DYSARTHRIA 279 0.0074
249 ASPIRATION 81 0.0074
250 PRESCRIBED OVERDOSE 143 0.0074
251 TROPONIN INCREASED 56 0.0074
252 HYPOMANIA 27 0.0073
253 SELF-MEDICATION 30 0.0073
254 BIPOLAR I DISORDER 16 0.0073
255 TACHYCARDIA 645 0.0073
256 NEUROTOXICITY 127 0.0072
257 ELECTROCARDIOGRAM T WAVE INVERSION 16 0.0072
258 TENSION 44 0.0072
259 HYPONATRAEMIA 406 0.0072
260 DRUG LEVEL ABOVE THERAPEUTIC 33 0.0072
261 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 19 0.0071
262 ENDOTRACHEAL INTUBATION 20 0.0071
263 LOGORRHOEA 25 0.0071
264 STAPHYLOCOCCAL SEPSIS 35 0.0071
265 ABNORMAL BEHAVIOUR 280 0.0071
266 REBOUND EFFECT 79 0.0070
267 BLOOD CHLORIDE DECREASED 18 0.0070
268 BUNDLE BRANCH BLOCK RIGHT 32 0.0070
269 FLAT AFFECT 16 0.0069
270 BRADYPHRENIA 45 0.0069
271 PSYCHOMOTOR SKILLS IMPAIRED 18 0.0069
272 URINARY RETENTION 229 0.0069
273 HYPOVENTILATION 22 0.0067
274 ALCOHOL ABUSE 18 0.0067
275 PULSELESS ELECTRICAL ACTIVITY 28 0.0067
276 COMA 318 0.0067
277 LYMPHOCYTE COUNT DECREASED 118 0.0067
278 GENERALISED TONIC-CLONIC SEIZURE 110 0.0066
279 HAEMODYNAMIC INSTABILITY 50 0.0066
280 LEFT VENTRICULAR HYPERTROPHY 28 0.0065
281 POISONING 82 0.0065
282 PENIS DISORDER 16 0.0065
283 CARDIAC DYSFUNCTION 24 0.0064
284 DISORIENTATION 255 0.0064
285 CACHEXIA 33 0.0064
286 IMMOBILE 28 0.0064
287 NYSTAGMUS 34 0.0064
288 SUSPECTED SUICIDE 30 0.0064
289 PSYCHIATRIC SYMPTOM 47 0.0064
290 COGNITIVE DISORDER 296 0.0063
291 TOXICITY TO VARIOUS AGENTS 1065 0.0063
292 HALLUCINATION, VISUAL 133 0.0063
293 GAMBLING DISORDER 17 0.0063
294 NEPHROGENIC ANAEMIA 29 0.0063
295 APATHY 91 0.0062
296 HALLUCINATION 469 0.0062
297 WHITE BLOOD CELL COUNT INCREASED 238 0.0062
298 HOMICIDAL IDEATION 25 0.0062
299 BRONCHOPNEUMONIA 21 0.0061
300 DYSPHORIA 31 0.0061
301 SCREAMING 39 0.0061
302 PERSONALITY DISORDER 16 0.0061
303 CARDIO-RESPIRATORY ARREST 255 0.0061
304 TONGUE DISORDER 44 0.0061
305 SEXUAL DYSFUNCTION 71 0.0060
306 BLOOD ALBUMIN DECREASED 48 0.0060
307 HYPERPHAGIA 24 0.0060
308 DRUG LEVEL BELOW THERAPEUTIC 33 0.0060
309 BIPOLAR DISORDER 65 0.0060
310 BRADYCARDIA 315 0.0059
311 BUNDLE BRANCH BLOCK LEFT 25 0.0059
312 ISCHAEMIA 27 0.0059
313 GASTROINTESTINAL NECROSIS 17 0.0058
314 WRONG PATIENT RECEIVED PRODUCT 17 0.0058
315 MONOCYTE COUNT INCREASED 21 0.0058
316 PERIORBITAL OEDEMA 30 0.0058
317 TACHYPHRENIA 20 0.0058
318 AZOTAEMIA 23 0.0058
319 AGRANULOCYTOSIS 107 0.0058
320 BRAIN OEDEMA 72 0.0057
321 ENURESIS 23 0.0057
322 METABOLIC ENCEPHALOPATHY 17 0.0057
323 ORTHOPNOEA 18 0.0056
324 WEIGHT INCREASED 1264 0.0056
325 MAJOR DEPRESSION 41 0.0056
326 VENTRICULAR TACHYCARDIA 92 0.0056
327 DRUG RESISTANCE 143 0.0056
328 COMPLETED SUICIDE 463 0.0056
329 DYSPHEMIA 24 0.0055
330 MULTIPLE DRUG OVERDOSE 27 0.0054
331 CARDIAC ARREST 447 0.0054
332 LEFT VENTRICULAR DYSFUNCTION 36 0.0054
333 THERAPY PARTIAL RESPONDER 83 0.0053
334 MYDRIASIS 68 0.0053
335 HYPERTRIGLYCERIDAEMIA 31 0.0053
336 REBOUND ACID HYPERSECRETION 16 0.0053
337 INCOHERENT 34 0.0052
338 ATAXIA 62 0.0052
339 BREAST ENLARGEMENT 17 0.0052
340 RESPIRATORY FAILURE 377 0.0052
341 ORTHOSTATIC HYPOTENSION 90 0.0052
342 HYPOXIA 182 0.0052
343 CARDIOPULMONARY FAILURE 20 0.0051
344 INCONTINENCE 54 0.0051
345 VENTRICULAR EXTRASYSTOLES 53 0.0051
346 NEUTROPHILIA 29 0.0051
347 CYANOSIS 80 0.0051
348 URINARY INCONTINENCE 150 0.0051
349 SNORING 19 0.0050
350 TOXIC ENCEPHALOPATHY 25 0.0049
351 RESPIRATORY DISTRESS 136 0.0049
352 PETIT MAL EPILEPSY 25 0.0049
353 GRAND MAL CONVULSION 45 0.0049
354 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 16 0.0048
355 ELECTROLYTE IMBALANCE 56 0.0048
356 TYPE 1 DIABETES MELLITUS 29 0.0048
357 ACUTE PULMONARY OEDEMA 27 0.0048
358 BLOOD TRIGLYCERIDES INCREASED 85 0.0048
359 SUICIDAL BEHAVIOUR 20 0.0048
360 CARDIAC FAILURE ACUTE 32 0.0048
361 CARDIOMYOPATHY 71 0.0048
362 EOSINOPHIL COUNT INCREASED 40 0.0048
363 EATING DISORDER 102 0.0048
364 FIBRIN D DIMER INCREASED 17 0.0048
365 PROTEIN TOTAL DECREASED 18 0.0048
366 ASPHYXIA 39 0.0048
367 PLATELET COUNT INCREASED 62 0.0048
368 INTENTIONAL OVERDOSE 304 0.0047
369 CONFUSIONAL STATE 759 0.0047
370 APNOEA 36 0.0046
371 THINKING ABNORMAL 86 0.0046
372 ACUTE RESPIRATORY FAILURE 87 0.0045
373 OLIGURIA 28 0.0045
374 AMMONIA INCREASED 23 0.0045
375 HYPERTRANSAMINASAEMIA 31 0.0045
376 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 17 0.0044
377 DIABETIC NEUROPATHY 22 0.0044
378 FOETAL DEATH 23 0.0044
379 PHOTOPSIA 28 0.0044
380 ILEUS 55 0.0044
381 PULSE ABSENT 21 0.0044
382 POLYURIA 36 0.0044
383 NEUTROPHIL COUNT DECREASED 178 0.0044
384 THERAPY NON-RESPONDER 196 0.0044
385 HYPERCHOLESTEROLAEMIA 42 0.0043
386 ATRIOVENTRICULAR BLOCK COMPLETE 29 0.0043
387 SUICIDAL IDEATION 396 0.0043
388 TREMOR 714 0.0043
389 LETHARGY 247 0.0043
390 ATRIAL FLUTTER 34 0.0043
391 METABOLIC ACIDOSIS 136 0.0042
392 MENTAL DISORDER 185 0.0042
393 SOMNOLENCE 855 0.0042
394 BLOOD UREA INCREASED 71 0.0042
395 FAILURE TO THRIVE 22 0.0042
396 SPEECH DISORDER 221 0.0042
397 ELECTROCARDIOGRAM ABNORMAL 33 0.0042
398 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 40 0.0042
399 GASTRIC INFECTION 16 0.0042
400 SARS-COV-2 TEST POSITIVE 55 0.0042
401 STEVENS-JOHNSON SYNDROME 92 0.0041
402 MYOCARDIAL ISCHAEMIA 47 0.0041
403 C-REACTIVE PROTEIN INCREASED 150 0.0041
404 BLOOD CHOLESTEROL ABNORMAL 19 0.0041
405 CIRCULATORY COLLAPSE 70 0.0041
406 HYPOTONIA 41 0.0041
407 NEUTROPENIA 551 0.0040
408 ENCEPHALITIS 28 0.0040
409 MUSCLE TWITCHING 93 0.0040
410 ODYNOPHAGIA 24 0.0040
411 HYPERPYREXIA 17 0.0040
412 BODY TEMPERATURE INCREASED 81 0.0040
413 EPILEPSY 121 0.0040
414 FOETAL GROWTH RESTRICTION 24 0.0039
415 EOSINOPHILIA 69 0.0039
416 COORDINATION ABNORMAL 54 0.0039
417 HYPOKALAEMIA 178 0.0039
418 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 99 0.0038
419 DYSPHAGIA 365 0.0038
420 IRRITABILITY 231 0.0038
421 CONGESTIVE CARDIOMYOPATHY 16 0.0038
422 JAW DISORDER 21 0.0038
423 RESPIRATORY RATE INCREASED 34 0.0038
424 PULMONARY EMBOLISM 361 0.0038
425 DERMATITIS EXFOLIATIVE 19 0.0038
426 BLOOD LACTIC ACID INCREASED 20 0.0038
427 PULMONARY CONGESTION 50 0.0038
428 RENAL TUBULAR NECROSIS 37 0.0038
429 FOOD POISONING 20 0.0037
430 POST-TRAUMATIC STRESS DISORDER 25 0.0037
431 MUCOSAL INFLAMMATION 97 0.0037
432 DRUG ABUSE 307 0.0037
433 SUBSTANCE ABUSE 30 0.0037
434 NORMAL NEWBORN 20 0.0037
435 MULTIPLE MYELOMA 17 0.0036
436 UMBILICAL HERNIA 17 0.0036
437 DRUG LEVEL DECREASED 37 0.0036
438 INTESTINAL ISCHAEMIA 20 0.0036
439 LUNG INFILTRATION 32 0.0036
440 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 197 0.0036
441 GLOMERULAR FILTRATION RATE DECREASED 44 0.0036
442 COVID-19 PNEUMONIA 42 0.0036
443 GLUCOSE TOLERANCE IMPAIRED 21 0.0035
444 PERICARDIAL EFFUSION 82 0.0035
445 DEMENTIA 99 0.0035
446 HEPATITIS ACUTE 23 0.0035
447 GENERAL PHYSICAL CONDITION ABNORMAL 24 0.0035
448 DIABETES MELLITUS 269 0.0035
449 WITHDRAWAL SYNDROME 148 0.0035
450 ACUTE RESPIRATORY DISTRESS SYNDROME 62 0.0035
451 TYPE 2 DIABETES MELLITUS 118 0.0035
452 PSEUDOMONAS INFECTION 30 0.0035
453 CEREBRAL ISCHAEMIA 18 0.0035
454 CHOKING 68 0.0035
455 HYPERGLYCAEMIA 127 0.0035
456 VARICOSE VEIN 18 0.0035
457 HAEMOLYTIC ANAEMIA 31 0.0035
458 HEPATOCELLULAR INJURY 49 0.0035
459 RESPIRATORY ARREST 95 0.0034
460 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 245 0.0034
461 MOTOR DYSFUNCTION 35 0.0034
462 INFLAMMATORY MARKER INCREASED 17 0.0034
463 MOVEMENT DISORDER 110 0.0034
464 ERYSIPELAS 17 0.0034
465 DISTURBANCE IN ATTENTION 181 0.0034
466 HYPOALBUMINAEMIA 26 0.0033
467 BLOOD SODIUM DECREASED 63 0.0033
468 AFFECT LABILITY 32 0.0033
469 RENAL FAILURE ACUTE 140 0.0033
470 SEPTIC SHOCK 143 0.0033
471 MULTIPLE ORGAN DYSFUNCTION SYNDROME 93 0.0033
472 RENAL CELL CARCINOMA 16 0.0033
473 ACUTE KIDNEY INJURY 500 0.0033
474 MEDICATION ERROR 181 0.0033
475 CARDIOTOXICITY 29 0.0032
476 HYPOPHAGIA 83 0.0032
477 IMPAIRED GASTRIC EMPTYING 44 0.0032
478 HAEMATOCRIT DECREASED 64 0.0032
479 BLOOD ALKALINE PHOSPHATASE INCREASED 80 0.0032
480 GASTROENTERITIS 47 0.0032
481 DECUBITUS ULCER 26 0.0032
482 HYPERLIPIDAEMIA 38 0.0032
483 DERMATITIS BULLOUS 23 0.0032
484 HYPOKINESIA 46 0.0032
485 ARRHYTHMIA 150 0.0032
486 HYPOMAGNESAEMIA 44 0.0032
487 BLOOD LACTATE DEHYDROGENASE INCREASED 50 0.0032
488 HYPOGLYCAEMIA 153 0.0032
489 ASPARTATE AMINOTRANSFERASE INCREASED 167 0.0031
490 NERVOUS SYSTEM DISORDER 98 0.0031
491 SEIZURE 362 0.0031
492 SHOCK 72 0.0031
493 END STAGE RENAL DISEASE 57 0.0031
494 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 16 0.0031
495 WRONG PRODUCT ADMINISTERED 21 0.0031
496 HEPATIC ENCEPHALOPATHY 29 0.0031
497 RESTLESS LEGS SYNDROME 56 0.0031
498 ABNORMAL WEIGHT GAIN 38 0.0031
499 ACUTE HEPATIC FAILURE 42 0.0031
500 HYDRONEPHROSIS 23 0.0031
501 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 23 0.0031
502 RASH MACULO-PAPULAR 68 0.0031
503 BLOOD CREATININE INCREASED 199 0.0030
504 ANGIOPATHY 17 0.0030
505 RENAL CYST 24 0.0030
506 ALANINE AMINOTRANSFERASE INCREASED 185 0.0030
507 HYPOTENSION 604 0.0030
508 ORAL DISORDER 22 0.0030
509 DISSEMINATED INTRAVASCULAR COAGULATION 42 0.0030
510 HAEMODIALYSIS 25 0.0030
511 ATRIOVENTRICULAR BLOCK 23 0.0030
512 AMENORRHOEA 52 0.0030
513 LIVER FUNCTION TEST ABNORMAL 86 0.0030
514 NEUTROPENIC SEPSIS 21 0.0029
515 TUBULOINTERSTITIAL NEPHRITIS 55 0.0029
516 UROSEPSIS 27 0.0029
517 TRANSAMINASES INCREASED 65 0.0029
518 ATELECTASIS 28 0.0029
519 DRUG DISPENSING ERROR 44 0.0029
520 DIABETIC KETOACIDOSIS 69 0.0029
521 NO THERAPEUTIC RESPONSE 35 0.0029
522 DISSOCIATION 22 0.0029
523 PRODUCT PACKAGING ISSUE 27 0.0028
524 SWOLLEN TONGUE 88 0.0028
525 PERICARDITIS 47 0.0028
526 CONDITION AGGRAVATED 849 0.0028
527 CARDIOGENIC SHOCK 40 0.0028
528 HYPERCALCAEMIA 34 0.0028
529 GENERAL PHYSICAL HEALTH DETERIORATION 318 0.0027
530 MUSCULOSKELETAL STIFFNESS 240 0.0027
531 CLOSTRIDIUM DIFFICILE COLITIS 29 0.0027
532 SEPSIS 305 0.0027
533 PURPURA 24 0.0027
534 PERSONALITY CHANGE 25 0.0027
535 HYPERHIDROSIS 346 0.0027
536 GAMMA-GLUTAMYLTRANSFERASE INCREASED 59 0.0027
537 LOSS OF CONSCIOUSNESS 338 0.0026
538 CONVULSION 150 0.0026
539 THROMBOCYTOPENIA 291 0.0026
540 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 23 0.0026
541 MALNUTRITION 29 0.0026
542 SOMNAMBULISM 17 0.0026
543 STATUS EPILEPTICUS 29 0.0026
544 ANURIA 22 0.0026
545 JOINT DISLOCATION 27 0.0026
546 URINE OUTPUT DECREASED 22 0.0025
547 TOXIC SKIN ERUPTION 25 0.0025
548 DEPRESSED MOOD 131 0.0025
549 ERECTILE DYSFUNCTION 63 0.0025
550 HYPOTHYROIDISM 78 0.0024
551 BODY TEMPERATURE DECREASED 24 0.0024
552 BLOOD MAGNESIUM DECREASED 21 0.0024
553 CEREBRAL DISORDER 18 0.0024
554 HEPATIC CYTOLYSIS 31 0.0024
555 MYOPATHY 21 0.0024
556 OVERDOSE 523 0.0024
557 HAEMATEMESIS 61 0.0024
558 METASTASES TO CENTRAL NERVOUS SYSTEM 31 0.0024
559 PANCREATITIS ACUTE 54 0.0024
560 LOW BIRTH WEIGHT BABY 19 0.0024
561 WHITE BLOOD CELL COUNT DECREASED 259 0.0024
562 PYREXIA 823 0.0024
563 HYPOCALCAEMIA 45 0.0024
564 CONJUNCTIVITIS 44 0.0024
565 ACIDOSIS 18 0.0024
566 ORAL CANDIDIASIS 31 0.0024
567 MATERNAL EXPOSURE BEFORE PREGNANCY 16 0.0023
568 RENAL FAILURE 311 0.0023
569 RENAL FAILURE CHRONIC 18 0.0023
570 PELVIC FRACTURE 18 0.0023
571 HEPATIC STEATOSIS 43 0.0023
572 HYPERSOMNIA 66 0.0023
573 HEMIPARESIS 39 0.0023
574 SPINAL COMPRESSION FRACTURE 19 0.0023
575 ACUTE CORONARY SYNDROME 19 0.0023
576 PRODUCT ADMINISTRATION INTERRUPTED 18 0.0023
577 CELLULITIS 115 0.0023
578 FEAR 61 0.0023
579 MULTI-ORGAN FAILURE 39 0.0023
580 TREATMENT FAILURE 186 0.0022
581 THERAPY CHANGE 22 0.0022
582 EYELID OEDEMA 26 0.0022
583 PULMONARY OEDEMA 100 0.0022
584 ANAL INCONTINENCE 20 0.0022
585 LOWER RESPIRATORY TRACT INFECTION 101 0.0022
586 MITRAL VALVE INCOMPETENCE 25 0.0022
587 HYPERKALAEMIA 77 0.0022
588 SUPRAVENTRICULAR TACHYCARDIA 21 0.0022
589 ACCIDENTAL OVERDOSE 80 0.0022
590 PLEURAL EFFUSION 133 0.0022
591 MOUTH HAEMORRHAGE 16 0.0022
592 ECONOMIC PROBLEM 33 0.0022
593 RESPIRATORY DISORDER 65 0.0022
594 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 37 0.0022
595 HYPERTENSION 457 0.0022
596 HEPATOTOXICITY 48 0.0022
597 DRUG SCREEN POSITIVE 17 0.0021
598 RENAL IMPAIRMENT 180 0.0021
599 HYPERTHYROIDISM 31 0.0021
600 CHOLESTASIS 41 0.0021
601 BLOOD DISORDER 17 0.0021
602 LYMPHOPENIA 30 0.0021
603 PRODUCT USE IN UNAPPROVED INDICATION 525 0.0021
604 FACIAL PARALYSIS 18 0.0021
605 CHRONIC KIDNEY DISEASE 160 0.0021
606 MUSCLE TIGHTNESS 34 0.0021
607 ANOREXIA 27 0.0021
608 GASTRITIS 55 0.0021
609 METASTASES TO LUNG 24 0.0021
610 EMOTIONAL DISORDER 64 0.0021
611 EXPOSURE DURING PREGNANCY 129 0.0021
612 INTERNATIONAL NORMALISED RATIO INCREASED 59 0.0021
613 SLEEP DISORDER 146 0.0021
614 CONSTIPATION 451 0.0021
615 CARDIAC FAILURE 166 0.0021
616 AMNESIA 134 0.0021
617 EJECTION FRACTION DECREASED 32 0.0021
618 PLATELET COUNT DECREASED 219 0.0021
619 SKIN INFECTION 23 0.0020
620 NEPHROPATHY TOXIC 23 0.0020
621 ANXIETY 581 0.0020
622 BLOOD POTASSIUM INCREASED 33 0.0020
623 APHASIA 61 0.0020
624 DRUG WITHDRAWAL SYNDROME 176 0.0020
625 SPUTUM DISCOLOURED 19 0.0020
626 FOETAL EXPOSURE DURING PREGNANCY 159 0.0020
627 PALLOR 53 0.0019
628 OXYGEN SATURATION DECREASED 109 0.0019
629 HEPATOMEGALY 19 0.0019
630 PRODUCT ADMINISTRATION ERROR 39 0.0019
631 HOSPICE CARE 19 0.0019
632 DIABETES MELLITUS INADEQUATE CONTROL 34 0.0019
633 LIVE BIRTH 16 0.0019
634 ATRIAL SEPTAL DEFECT 16 0.0019
635 GYNAECOMASTIA 59 0.0019
636 ACUTE MYOCARDIAL INFARCTION 56 0.0019
637 CAESAREAN SECTION 22 0.0019
638 RED BLOOD CELL COUNT DECREASED 54 0.0019
639 HYPERTENSIVE CRISIS 21 0.0019
640 DEVELOPMENTAL DELAY 17 0.0019
641 HEPATITIS 48 0.0019
642 INTENTIONAL PRODUCT MISUSE 164 0.0019
643 ANGIOEDEMA 82 0.0019
644 BLOOD TEST ABNORMAL 26 0.0018
645 FRACTURE 35 0.0018
646 PYELONEPHRITIS 16 0.0018
647 UPPER GASTROINTESTINAL HAEMORRHAGE 31 0.0018
648 HYPERBILIRUBINAEMIA 19 0.0018
649 SLEEP APNOEA SYNDROME 35 0.0018
650 ANGER 62 0.0018
651 DEEP VEIN THROMBOSIS 119 0.0018
652 ANHEDONIA 48 0.0018
653 BEDRIDDEN 24 0.0018
654 DRUG WITHDRAWAL SYNDROME NEONATAL 27 0.0018
655 CONTRAINDICATED PRODUCT ADMINISTERED 55 0.0018
656 NOCTURIA 22 0.0018
657 PNEUMONIA 585 0.0018
658 ARTERIOSCLEROSIS 17 0.0018
659 INTESTINAL OBSTRUCTION 68 0.0018
660 ASCITES 53 0.0018
661 INSOMNIA 480 0.0018
662 APHONIA 25 0.0018
663 PANCYTOPENIA 100 0.0018
664 CARDIOMEGALY 22 0.0018
665 SYNCOPE 178 0.0018
666 BLOOD CALCIUM DECREASED 20 0.0018
667 GENERALISED OEDEMA 22 0.0018
668 ATRIAL FIBRILLATION 173 0.0018
669 SLUGGISHNESS 18 0.0018
670 PARALYSIS 25 0.0017
671 DEPRESSION 396 0.0017
672 BLOOD CHOLESTEROL INCREASED 81 0.0017
673 RETCHING 37 0.0017
674 BLOOD POTASSIUM DECREASED 52 0.0017
675 FEBRILE NEUTROPENIA 114 0.0017
676 HEPATIC FUNCTION ABNORMAL 64 0.0017
677 SPLENOMEGALY 20 0.0017
678 PNEUMOTHORAX 27 0.0017
679 ABASIA 42 0.0017
680 PREMATURE BABY 51 0.0017
681 DRUG ERUPTION 30 0.0017
682 RESPIRATORY TRACT INFECTION 44 0.0017
683 DRUG INEFFECTIVE 2226 0.0017
684 POISONING DELIBERATE 16 0.0017
685 EMPHYSEMA 17 0.0017
686 SUBDURAL HAEMATOMA 24 0.0017
687 HAEMOGLOBIN DECREASED 172 0.0017
688 FALL 557 0.0017
689 MATERNAL EXPOSURE DURING PREGNANCY 149 0.0017
690 BLOOD PRESSURE DECREASED 111 0.0017
691 STAPHYLOCOCCAL INFECTION 55 0.0017
692 OFF LABEL USE 1454 0.0017
693 DEHYDRATION 221 0.0017
694 LACTIC ACIDOSIS 53 0.0016
695 SMALL INTESTINAL OBSTRUCTION 20 0.0016
696 BLISTER 91 0.0016
697 OEDEMA PERIPHERAL 197 0.0016
698 CANDIDA INFECTION 27 0.0016
699 BLOOD BILIRUBIN INCREASED 43 0.0016
700 LYMPHADENOPATHY 56 0.0016
701 DECREASED ACTIVITY 17 0.0016
702 VOMITING 737 0.0016
703 INITIAL INSOMNIA 16 0.0016
704 THERAPEUTIC RESPONSE DECREASED 94 0.0015
705 GAIT DISTURBANCE 296 0.0015
706 FACE OEDEMA 26 0.0015
707 RED BLOOD CELL SEDIMENTATION RATE INCREASED 17 0.0015
708 PETECHIAE 16 0.0015
709 CENTRAL NERVOUS SYSTEM LESION 21 0.0015
710 HEPATIC FAILURE 46 0.0015
711 NEOPLASM PROGRESSION 53 0.0015
712 DRUG INTOLERANCE 147 0.0015
713 NEURALGIA 37 0.0015
714 BLOOD IRON DECREASED 18 0.0015
715 CHOLECYSTITIS 18 0.0015
716 NEUROPATHY PERIPHERAL 143 0.0015
717 NIGHTMARE 52 0.0015
718 DRUG-INDUCED LIVER INJURY 47 0.0015
719 CYTOKINE RELEASE SYNDROME 30 0.0015
720 BLOOD PRESSURE SYSTOLIC INCREASED 29 0.0015
721 HEAD INJURY 47 0.0015
722 MOOD ALTERED 40 0.0015
723 ANGINA PECTORIS 42 0.0015
724 PERITONITIS 30 0.0014
725 DENTAL CARIES 16 0.0014
726 COAGULOPATHY 24 0.0014
727 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 75 0.0014
728 URINARY TRACT INFECTION 245 0.0014
729 BACTERAEMIA 17 0.0014
730 DEVICE RELATED INFECTION 22 0.0014
731 MOUTH ULCERATION 30 0.0014
732 DYSURIA 52 0.0014
733 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 67 0.0014
734 POOR QUALITY SLEEP 30 0.0014
735 LIVER INJURY 34 0.0014
736 HEART RATE INCREASED 137 0.0014
737 HAEMATURIA 47 0.0014
738 CHOLELITHIASIS 45 0.0014
739 DYSSTASIA 40 0.0014
740 PANCREATITIS 72 0.0014
741 THIRST 24 0.0013
742 ANAEMIA 256 0.0013
743 DIALYSIS 19 0.0013
744 ABDOMINAL PAIN 310 0.0013
745 BONE MARROW FAILURE 27 0.0013
746 HEART RATE IRREGULAR 30 0.0013
747 HEPATITIS C 16 0.0013
748 DISEASE RECURRENCE 63 0.0013
749 DISEASE PROGRESSION 156 0.0013
750 SKIN LESION 36 0.0013
751 HOSPITALISATION 201 0.0013
752 RECTAL HAEMORRHAGE 56 0.0013
753 JAUNDICE 35 0.0013
754 MUSCULOSKELETAL CHEST PAIN 20 0.0013
755 MULTIPLE FRACTURES 21 0.0013
756 PRODUCTIVE COUGH 61 0.0013
757 VISION BLURRED 174 0.0013
758 ACTIVITIES OF DAILY LIVING IMPAIRED 25 0.0013
759 HYPOAESTHESIA ORAL 19 0.0013
760 MEMORY IMPAIRMENT 173 0.0013
761 INCORRECT ROUTE OF DRUG ADMINISTRATION 45 0.0013
762 BALANCE DISORDER 107 0.0012
763 DRUG EXPOSURE DURING PREGNANCY 42 0.0012
764 HAEMORRHOIDS 24 0.0012
765 HUNGER 17 0.0012
766 DRY MOUTH 99 0.0012
767 LIVER DISORDER 54 0.0012
768 DECREASED APPETITE 279 0.0012
769 INTENTIONAL DRUG MISUSE 25 0.0012
770 MOOD SWINGS 38 0.0012
771 BRONCHOSPASM 17 0.0012
772 COLITIS 44 0.0012
773 HEPATIC ENZYME INCREASED 78 0.0011
774 RENAL DISORDER 53 0.0011
775 BLOOD GLUCOSE ABNORMAL 21 0.0011
776 HEAD DISCOMFORT 20 0.0011
777 ABSCESS 18 0.0011
778 BACTERIAL INFECTION 21 0.0011
779 OSTEOPENIA 17 0.0011
780 LIVER FUNCTION TEST INCREASED 24 0.0011
781 TOOTH LOSS 23 0.0011
782 OEDEMA 60 0.0011
783 CARDIOVASCULAR DISORDER 28 0.0011
784 PNEUMONITIS 30 0.0011
785 PANIC ATTACK 40 0.0011
786 METASTASES TO BONE 18 0.0011
787 NERVOUSNESS 57 0.0011
788 ACUTE MYELOID LEUKAEMIA 17 0.0011
789 CHEST PAIN 202 0.0011
790 HIP FRACTURE 35 0.0011
791 ADVERSE DRUG REACTION 97 0.0011
792 COLD SWEAT 19 0.0011
793 WEIGHT DECREASED 299 0.0011
794 GASTROINTESTINAL HAEMORRHAGE 89 0.0011
795 ISCHAEMIC STROKE 19 0.0011
796 RASH MACULAR 37 0.0011
797 PULMONARY HYPERTENSION 22 0.0011
798 PRODUCT PRESCRIBING ISSUE 23 0.0011
799 DYSPEPSIA 103 0.0010
800 RENAL INJURY 31 0.0010
801 INFECTION 151 0.0010
802 JOINT STIFFNESS 27 0.0010
803 ABDOMINAL PAIN LOWER 26 0.0010
804 MALAISE 450 0.0010
805 BASAL CELL CARCINOMA 16 0.0010
806 DRUG EFFECT INCOMPLETE 37 0.0010
807 ABDOMINAL DISTENSION 106 0.0010
808 TRANSIENT ISCHAEMIC ATTACK 34 0.0010
809 BLINDNESS 41 0.0010
810 RASH GENERALISED 26 0.0010
811 UPPER RESPIRATORY TRACT INFECTION 46 0.0010
812 GLYCOSYLATED HAEMOGLOBIN INCREASED 25 0.0010
813 MALIGNANT NEOPLASM PROGRESSION 101 0.0010
814 DYSPNOEA 557 0.0010
815 POLLAKIURIA 41 0.0010
816 CEREBRAL INFARCTION 24 0.0010
817 LUNG DISORDER 48 0.0010
818 ASTHENIA 366 0.0010
819 METASTASES TO LIVER 17 0.0010
820 VIRAL INFECTION 32 0.0010
821 ADVERSE EVENT 88 0.0010
822 MELAENA 21 0.0010
823 INFLAMMATION 49 0.0009
824 DRUG EFFECT DECREASED 51 0.0009
825 FULL BLOOD COUNT DECREASED 19 0.0009
826 CHILLS 110 0.0009
827 GASTROINTESTINAL DISORDER 84 0.0009
828 FEMUR FRACTURE 29 0.0009
829 BONE DISORDER 17 0.0009
830 LOCAL SWELLING 16 0.0009
831 CYSTITIS 29 0.0009
832 INTERSTITIAL LUNG DISEASE 44 0.0009
833 GASTROOESOPHAGEAL REFLUX DISEASE 73 0.0009
834 ANAPHYLACTIC REACTION 50 0.0009
835 PRESCRIBED UNDERDOSE 18 0.0009
836 DIARRHOEA 582 0.0009
837 OSTEOARTHRITIS 38 0.0009
838 GASTRIC ULCER 17 0.0009
839 MOBILITY DECREASED 64 0.0009
840 CHROMATURIA 20 0.0009
841 POST PROCEDURAL COMPLICATION 17 0.0009
842 ROAD TRAFFIC ACCIDENT 37 0.0009
843 NAUSEA 689 0.0009
844 CLOSTRIDIUM DIFFICILE INFECTION 19 0.0009
845 GAIT INABILITY 29 0.0009
846 THERAPY CESSATION 44 0.0009
847 DEATH 737 0.0009
848 CARDIAC DISORDER 80 0.0009
849 HEPATIC CIRRHOSIS 16 0.0009
850 SKIN ULCER 22 0.0009
851 PHOTOPHOBIA 16 0.0008
852 DYSPNOEA EXERTIONAL 32 0.0008
853 PLASMA CELL MYELOMA 33 0.0008
854 INTENTIONAL DOSE OMISSION 24 0.0008
855 RHINORRHOEA 54 0.0008
856 PRODUCT USE ISSUE 157 0.0008
857 EMOTIONAL DISTRESS 101 0.0008
858 BLOOD PRESSURE FLUCTUATION 20 0.0008
859 VISUAL IMPAIRMENT 103 0.0008
860 FAECES DISCOLOURED 18 0.0008
861 TINNITUS 38 0.0008
862 HEART RATE DECREASED 29 0.0008
863 CORONARY ARTERY DISEASE 25 0.0008
864 CRYING 30 0.0008
865 EYE DISORDER 27 0.0008
866 COVID-19 144 0.0008
867 RASH ERYTHEMATOUS 39 0.0008
868 KIDNEY INFECTION 16 0.0008
869 SWELLING FACE 53 0.0008
870 CEREBRAL HAEMORRHAGE 29 0.0008
871 MUSCULAR WEAKNESS 91 0.0008
872 HAEMOPTYSIS 22 0.0008
873 MYALGIA 133 0.0008
874 DRUG ADMINISTRATION ERROR 24 0.0008
875 OCULAR HYPERAEMIA 37 0.0008
876 RIB FRACTURE 16 0.0008
877 BLOOD PRESSURE INCREASED 118 0.0008
878 BLOOD GLUCOSE INCREASED 145 0.0008
879 INJURY 54 0.0008
880 WOUND 21 0.0008
881 MUSCLE SPASMS 136 0.0007
882 DIZZINESS 369 0.0007
883 ANAPHYLACTIC SHOCK 19 0.0007
884 NECK PAIN 41 0.0007
885 DIPLOPIA 19 0.0007
886 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
887 FATIGUE 567 0.0007
888 WHEEZING 43 0.0007
889 FEELING ABNORMAL 173 0.0007
890 FEELING HOT 44 0.0007
891 PRODUCT PRESCRIBING ERROR 17 0.0007
892 INTENTIONAL PRODUCT USE ISSUE 62 0.0007
893 ABORTION SPONTANEOUS 28 0.0007
894 LACRIMATION INCREASED 21 0.0007
895 PALPITATIONS 81 0.0007
896 LIP SWELLING 23 0.0007
897 CEREBROVASCULAR ACCIDENT 116 0.0007
898 DYSPHONIA 40 0.0007
899 OROPHARYNGEAL PAIN 63 0.0007
900 ALOPECIA 130 0.0007
901 INCORRECT DOSE ADMINISTERED 151 0.0007
902 OSTEOPOROSIS 27 0.0007
903 VERTIGO 40 0.0007
904 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 19 0.0006
905 PERIPHERAL SWELLING 99 0.0006
906 COUGH 180 0.0006
907 CONTUSION 61 0.0006
908 MYOCARDIAL INFARCTION 110 0.0006
909 THERAPEUTIC PRODUCT EFFECT DECREASED 28 0.0006
910 HYPERSENSITIVITY 116 0.0006
911 CATARACT 37 0.0006
912 ABNORMAL DREAMS 17 0.0006
913 EPISTAXIS 46 0.0006
914 DEAFNESS 16 0.0006
915 WRONG TECHNIQUE IN DRUG USAGE PROCESS 22 0.0006
916 CARDIAC FAILURE CONGESTIVE 48 0.0006
917 DISCOMFORT 36 0.0006
918 FLATULENCE 33 0.0006
919 THERAPEUTIC RESPONSE UNEXPECTED 26 0.0006
920 STOMATITIS 35 0.0006
921 MIGRAINE 55 0.0006
922 FEELING COLD 16 0.0006
923 ABDOMINAL PAIN UPPER 114 0.0006
924 FLUID RETENTION 28 0.0005
925 UNEVALUABLE EVENT 41 0.0005
926 SKIN EXFOLIATION 45 0.0005
927 HAEMATOCHEZIA 29 0.0005
928 LIMB DISCOMFORT 16 0.0005
929 SKIN DISORDER 17 0.0005
930 THROMBOSIS 41 0.0005
931 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 17 0.0005
932 PAIN 309 0.0005
933 HYPOAESTHESIA 75 0.0005
934 BACK PAIN 116 0.0005
935 CHEST DISCOMFORT 51 0.0005
936 HEADACHE 312 0.0005
937 MUSCULOSKELETAL PAIN 26 0.0005
938 PRURITUS 188 0.0005
939 PRODUCT SUBSTITUTION ISSUE 28 0.0005
940 BONE PAIN 28 0.0005
941 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 34 0.0005
942 SURGERY 28 0.0005
943 ERYTHEMA 96 0.0005
944 LUNG NEOPLASM MALIGNANT 19 0.0005
945 ACNE 35 0.0005
946 BRONCHITIS 34 0.0005
947 SKIN DISCOLOURATION 21 0.0005
948 EYE SWELLING 17 0.0005
949 RASH 199 0.0005
950 ABDOMINAL DISCOMFORT 75 0.0004
951 ILL-DEFINED DISORDER 27 0.0004
952 HOT FLUSH 33 0.0004
953 INFLUENZA LIKE ILLNESS 36 0.0004
954 BLOOD GLUCOSE DECREASED 21 0.0004
955 NEOPLASM MALIGNANT 29 0.0004
956 RASH PRURITIC 23 0.0004
957 DRUG DEPENDENCE 68 0.0004
958 HAEMORRHAGE 44 0.0004
959 NEPHROLITHIASIS 19 0.0004
960 ARTHRITIS 32 0.0004
961 SWELLING 38 0.0004
962 PARAESTHESIA 63 0.0004
963 ECZEMA 20 0.0004
964 PAIN IN EXTREMITY 108 0.0004
965 ARTHROPATHY 20 0.0004
966 JOINT SWELLING 43 0.0004
967 UNDERDOSE 26 0.0004
968 INFLUENZA 39 0.0003
969 FLUSHING 35 0.0003
970 BREAST CANCER 30 0.0003
971 THERAPY INTERRUPTED 23 0.0003
972 PRODUCT DOSE OMISSION 21 0.0003
973 DRY EYE 16 0.0003
974 ASTHMA 35 0.0003
975 ARTHRALGIA 124 0.0003
976 NASOPHARYNGITIS 54 0.0003
977 DRUG DOSE OMISSION 48 0.0003
978 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 51 0.0003
979 NO ADVERSE EVENT 51 0.0003
980 PRODUCT QUALITY ISSUE 37 0.0003
981 NASAL CONGESTION 16 0.0003
982 BURNING SENSATION 18 0.0003
983 DYSGEUSIA 18 0.0002
984 ACCIDENTAL EXPOSURE TO PRODUCT 24 0.0002
985 URTICARIA 39 0.0002
986 PSORIASIS 30 0.0002
987 PRODUCT DOSE OMISSION ISSUE 67 0.0002
988 ILLNESS 22 0.0002
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 36 0.0002
990 SINUSITIS 18 0.0002
991 DRY SKIN 20 0.0001
992 INJECTION SITE ERYTHEMA 16 0.0001
993 INJECTION SITE PAIN 38 0.0001